Preliminary Experience With Alemtuzumab Induction Therapy Combined With Maintenance Low-Dose Tacrolimus Monotherapy in Small-Bowel Transplantation in China
To access this article, please choose from the options below
This study was supported by grant 2008BAI60B06 from the National Key Technologies R&D Program in the Eleventh Five-Year Plan, Ministry of Science and Technology of the People's Republic of China.
PII: S0041-1345(09)01784-9
doi:10.1016/j.transproceed.2009.12.028
© 2010 Elsevier Inc. All rights reserved.
